Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Abdel G Babiker"'
Autor:
Christine Grady, Giota Touloumi, A Sarah Walker, Mary Smolskis, Shweta Sharma, Abdel G Babiker, Nikos Pantazis, Jorge Tavel, Eric Florence, Adriana Sanchez, Fleur Hudson, Antonios Papadopoulos, Ezekiel Emanuel, Megan Clewett, David Munroe, Eileen Denning, INSIGHT START Informed Consent Substudy Group
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0172607 (2017)
BackgroundImproving the effectiveness and efficiency of research informed consent is a high priority. Some express concern about longer, more complex, written consent forms creating barriers to participant understanding. A recent meta-analysis conclu
Externí odkaz:
https://doaj.org/article/b91ef53d43734040bb0b646cfad27080
Autor:
Fabiola Martin, Hannah Castro, Carolyn Gabriel, Adine Adonis, Alexandra Fedina, Linda Harrison, Liz Brodnicki, Maria A Demontis, Abdel G Babiker, Jonathan N Weber, Charles R M Bangham, Graham P Taylor
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 6, p e1675 (2012)
Patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) become progressively impaired, with chronic pain, immobility and bladder, bowel and sexual dysfunction. Tested antiretroviral therapies have not been effective and most
Externí odkaz:
https://doaj.org/article/4102ad7d5c774e5daaac7cb7ab4a4eb6
Autor:
Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33672 (2012)
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.Cost-effectiveness analysis was
Externí odkaz:
https://doaj.org/article/77a1520ae5834f208c0ebd0d9106a0b8
Autor:
Elizabeth C. George, Sarah Kiguli, Peter Olupot Olupot, Robert O. Opoka, Charles Engoru, Samuel O. Akech, Richard Nyeko, George Mtove, Ayub Mpoya, Margaret J. Thomason, Jane Crawley, Jennifer A. Evans, Diana M. Gibb, Abdel G. Babiker, Kathryn Maitland, A. Sarah Walker
Publikováno v:
Critical Care, Vol 23, Iss 1, Pp 1-9 (2019)
Abstract Background African children hospitalised with severe febrile illness have a high risk of mortality. The Fluid Expansion As Supportive Therapy (FEAST) trial (ISCRTN 69856593) demonstrated increased mortality risk associated with fluid boluses
Externí odkaz:
https://doaj.org/article/4a1e36db224240a68a1c152efaca72ad
Autor:
Ella Marley-Zagar, Ian R. White, Patrick Royston, Friederike M.-S. Barthel, Mahesh K. B. Parmar, Abdel G. Babiker
Publikováno v:
The Stata Journal: Promoting communications on statistics and Stata. 23:24-52
We describe the command artbin, which offers various new facilities for the calculation of sample size for binary outcome variables that are not otherwise available in Stata. While artbin has been available since 2004, it has not been previously desc
Autor:
Cavan S Reilly, Álvaro H Borges, Jason V Baker, Sandra E Safo, Shweta Sharma, Mark N Polizzotto, James S Pankow, Xiaojun Hu, Brad T Sherman, Abdel G Babiker, Jens D Lundgren, H Clifford Lane
Publikováno v:
The Journal of Infectious Diseases. 227:951-960
Background There is an incompletely understood increased risk for cardiovascular disease (CVD) among people with HIV (PWH). We investigated if a collection of biomarkers were associated with CVD among PWH. Mendelian randomization (MR) was used to ide
Autor:
Ian R. White, Ella Marley-Zagar, Tim P. Morris, Mahesh K. B. Parmar, Patrick Royston, Abdel G. Babiker
Publikováno v:
Stata J
We describe a new command, artcat, that calculates sample size or power for a randomized controlled trial or similar experiment with an ordered categorical outcome, where analysis is by the proportional-odds model. artcat implements the method of Whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c420e6e67920857687e2c9fe51f4697c
https://europepmc.org/articles/PMC7614472/
https://europepmc.org/articles/PMC7614472/
Autor:
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Mamta K. Jain, Susana M. Lazarte, Jason V. Baker, Anne E.P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Arnoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S. Taha, Thomas Benfield, Sean T.H. Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen MD, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G. Koulouris, Robin Trotman, Amy C. Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J. Malin, Christoph Lübbert, Jose Muñoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolskis, Giota Touloumi, Mary E. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V. Thakuria, Leman Yel, Elizabeth Higgs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane
Publikováno v:
Lancet (London, England)
Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific therapy for an outbreak infection such as SARS-CoV-2. Findings from randomi
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-21 (2016)
Abstract Background There has been some debate in the literature as to whether baseline values of a measurement of interest at treatment initiation should be treated as an outcome variable as part of a model for longitudinal change or instead used as
Externí odkaz:
https://doaj.org/article/eff9b0cfa0ab4adf8d6c4182bb48c3ef
Autor:
Abdel G Babiker, Jens Lundgren, Shweta Sharma, Birgit Grund, Andrew Phillips, Virginia L Kan, Gail Matthews, Karin L Klingman, James D Neaton
Publikováno v:
Open Forum Infectious Diseases. 9
Background Deferral of antiretroviral therapy (ART) initiation until CD4 count < 350 cells/μL in people with CD4 > 500 increases risk of AIDS and serious non-AIDS (SNA) conditions. Evidence from randomized trials is lacking to assess the extent to w